Abstract | AIM: PATIENTS AND METHODS: We treated 12 dogs with TVT with 1-4 intratumoral treatments with vincristine and IL-2. Per treatment we used vincristine (0.5-0.7 mg/m(2)) and IL2 (2×10(6) units). The injections were given at weekly intervals. RESULTS: Early therapeutic effects were: three complete regressions, four partial regressions, three stable disease, and two progressive disease. Late therapeutic effects were established 45-60 months after the first presentation; there were five complete regressions, no partial regressions, nor stable or progressive diseases. Interestingly, all five dogs with late therapeutic effects were in good health. No tumor recurrence was noted. CONCLUSION:
|
Authors | Willem DEN Otter, Margot Hack, John J L Jacobs, Jurgen F V Tan, Lawrence Rozendaal, R Jeroen A VAN Moorselaar |
Journal | Anticancer research
(Anticancer Res)
Vol. 35
Issue 6
Pg. 3385-91
(Jun 2015)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 26026099
(Publication Type: Journal Article)
|
Copyright | Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- Antineoplastic Agents, Phytogenic
- Interleukin-2
- Vincristine
|
Topics |
- Animals
- Antineoplastic Agents, Phytogenic
(administration & dosage)
- Dogs
- Female
- Humans
- Interleukin-2
(administration & dosage)
- Male
- Neoplasm Recurrence, Local
(drug therapy, pathology, veterinary)
- Treatment Outcome
- Venereal Tumors, Veterinary
(drug therapy, pathology)
- Vincristine
(administration & dosage)
|